Clinical trial Recruiting at 3 sites Interventional Ages 18 to 79

Targeted thalamic ultrasound to help recovery after severe brain injury

Official title: Safety and Efficacy of Thalamic Focused Ultrasound Stimulation (tFUS) for Promoting Recovery After Severe Traumatic Brain Injury

Run by University of California, Los Angeles · NCT06939348 · Data updated 2026-11-12

This will try focused ultrasound to the thalamus to see if it helps people with a prolonged disorder of consciousness after traumatic brain injury.

More Disorders of Consciousness trials

Quick facts

Study typeInterventional
Ages18 Years to 79 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations4 sites (Los Angeles, California and 3 other locations)
StatusRecruiting
StartedApril 26, 2025
Main results expectedMarch 28, 2028
Study endsSeptember 29, 2028
Registry record updatedMay 22, 2026
Trial IDNCT06939348 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Patients with a diagnosis of prolonged disorder of consciousness (>28 days post–traumatic brain injury) confirmed by CRS-R, with a legally authorized representative to consent and stable psychotropic medication regimens, are the intended participants.

Probably not a fit

Patients with non‑TBI causes of DoC, unstable medical needs (including mechanical ventilation), certain skull surgeries or implants, or MRI contraindications are unlikely to be eligible or to derive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, double-blind, sham-controlled randomized study tests low-intensity focused ultrasound (tFUS) delivered to the thalamus in patients with prolonged disorders of consciousness after traumatic brain injury. Forty patients more than 28 days post-injury will be randomized to either two active tFUS sessions or a sham session followed by tFUS, with assessments before and one week after sonication. Primary outcome is the Coma Recovery Scale–Revised (CRS-R) and a secondary outcome is the Disability Rating Scale, while safety, dose effects, and preliminary biomarkers of response will also be examined. The procedure uses the Brainsonix BX Pulsar 1002 and the sham mimics the setup using a non-transmitting gel pad.

Why it matters

Potential benefit: If successful, tFUS could speed recovery of consciousness and improve functional outcomes for some patients with prolonged DoC after TBI.

How similar studies have gone: Small pilot studies and prior procedures have reported preliminary signals that thalamic focused ultrasound can modulate arousal, but randomized controlled evidence in prolonged DoC is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosis of DoC, following international guidelines, as assessed with the CRS-R.
2. Prolonged status (\>28days post-injury)
3. If on a psychotropic medication regimen, that regimen will be stable for at least 4 weeks prior to entry to the study and the patient will be willing to remain on a stable regimen during the protocol.
4. legally authorized representative available to consent for the patient to participate in the study

Exclusion Criteria:

1. History of neurological disorder (other than the brain injury).
2. Metal implant or other condition precluding safe entry in the MR-environment.
3. Manifest continuous spontaneous movement (which would prevent safe/successful imaging).
4. Participation in another concurrent clinical trial.
5. Need for mechanical ventilation.
6. Craniotomy (no bone flap).
7. Cranioplasty spanning the left temporal bone window.

Where it's running

  • The Regents of the University of California, Los Angeles
    Los Angeles, California, United States
    Recruiting
  • Casa Colina Hospital and Centers for Healthcare
    Pomona, California, United States
    Recruiting
  • Massachusetts General Hospital (The General Hospital Corp.)
    Boston, Massachusetts, United States
    Recruiting
  • Spaulding Rehabilitation Hospital Corporation, Inc.
    Charlestown, Massachusetts, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Martin M Monti, PhD — University of California, Los Angeles
  • Study coordinator: Martin M Monti, PhD
  • Email: monti@psych.ucla.edu
  • Phone: 310-825-8546

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.